| The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for … GM McKhann, DS Knopman, H Chertkow, BT Hyman, CR Jack Jr, ... Alzheimer's & dementia 7 (3), 263-269, 2011 | 15585 | 2011 |
| Current concepts in mild cognitive impairment RC Petersen, R Doody, A Kurz, RC Mohs, JC Morris, PV Rabins, K Ritchie, ... Archives of neurology 58 (12), 1985-1992, 2001 | 6543 | 2001 |
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. JC Morris, A Heyman, RC Mohs, JP Hughes, G van Belle, G Fillenbaum, ... Neurology 39 (9), 1159-1165, 1989 | 5409* | 1989 |
| A new rating scale for Alzheimer's disease. WG Rosen, RC Mohs, KL Davis The American journal of psychiatry 141 (11), 1356-1364, 1984 | 5127 | 1984 |
| A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease SL Rogers, MR Farlow, RS Doody, R Mohs, LT Friedhoff, ... Neurology 50 (1), 136-145, 1998 | 2161 | 1998 |
| Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease RS Doody, RG Thomas, M Farlow, T Iwatsubo, B Vellas, S Joffe, ... New England Journal of Medicine 370 (4), 311-321, 2014 | 1740 | 2014 |
| Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline J Näslund, V Haroutunian, R Mohs, KL Davis, P Davies, P Greengard, ... Jama 283 (12), 1571-1577, 2000 | 1715 | 2000 |
| Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior EF Coccaro, LJ Siever, HM Klar, G Maurer, K Cochrane, TB Cooper, ... Archives of general psychiatry 46 (7), 587-599, 1989 | 1556 | 1989 |
| Practice parameter: Management of dementia (an evidence-based review)[RETIRED] Report of the Quality Standards Subcommittee of the American Academy of Neurology RS Doody, JC Stevens, C Beck, RM Dubinsky, JA Kaye, L Gwyther, ... Neurology 56 (9), 1154-1166, 2001 | 1341 | 2001 |
| A phase 3 trial of semagacestat for treatment of Alzheimer's disease RS Doody, R Raman, M Farlow, T Iwatsubo, B Vellas, S Joffe, K Kieburtz, ... New England Journal of Medicine 369 (4), 341-350, 2013 | 1282 | 2013 |
| Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials M Grundman, RC Petersen, SH Ferris, RG Thomas, PS Aisen, DA Bennett, ... Archives of neurology 61 (1), 59-66, 2004 | 1237 | 2004 |
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery KA Welsh, N Butters, RC Mohs, D Beekly, S Edland, G Fillenbaum, ... Neurology 44 (4), 609-609, 1994 | 1159 | 1994 |
| Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures K Welsh, N Butters, J Hughes, R Mohs, A Heyman Archives of neurology 48 (3), 278-281, 1991 | 1045 | 1991 |
| Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study SL Rogers, RS Doody, RC Mohs, LT Friedhoff, Donepezil Study Group Archives of internal medicine 158 (9), 1021-1031, 1998 | 986 | 1998 |
| High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging LF Berkman, TE Seeman, M Albert, D Blazer, R Kahn, R Mohs, C Finch, ... Journal of clinical epidemiology 46 (10), 1129-1140, 1993 | 764 | 1993 |
| Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease KA Welsh, N Butters, JP Hughes, RC Mohs, A Heyman Archives of neurology 49 (5), 448-452, 1992 | 763 | 1992 |
| Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope RC Mohs, D Knopman, RC Petersen, SH Ferris, C Ernesto, M Grundman, ... Alzheimer Disease & Associated Disorders 11, 13-21, 1997 | 732 | 1997 |
| Cholinergic markers in elderly patients with early signs of Alzheimer disease KL Davis, RC Mohs, D Marin, DP Purohit, DP Perl, M Lantz, G Austin, ... Jama 281 (15), 1401-1406, 1999 | 722 | 1999 |
| A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients RC Mohs, RS Doody, JC Morris, JR Ieni, SL Rogers, CA Perdomo, ... Neurology 57 (3), 481-488, 2001 | 655 | 2001 |
| Drug discovery and development: Role of basic biological research RC Mohs, NH Greig Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (4 …, 2017 | 610 | 2017 |
Jeremy M. SilvermanProfessor of Psychiatry, Icahn School of Medicine at Mount SinaiVerified email at mssm.edu
